Hapten-Induced Model of Murine Inflammatory Bowel Disease: Mucosal Immune Responses and Protection by Tolerance

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2174-2185

  Elson, Charles O ^a   Beagley, Kenneth W ^c   Sharmanov, Almaz T ^a   Fujihashi, Kohtaro ^b   Kiyono, Hiroshi ^b,d   Tennyson, Gary S ^a   Cong, Yingzi ^a   Allen Black, C ^c   Ridwan, Ben W ^a   McGhee, Jerry R ^b,e  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d OSAKA UNIVERSITY   (Japan)

^e University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; HAPTEN; IMMUNOSUPPRESSIVE AGENT; NITROBENZENE DERIVATIVE; TRINITROBENZENESULFONIC ACID;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; CD4+ T LYMPHOCYTE; DBA MOUSE; DISEASE MODEL; ENTERITIS; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTESTINE MUCOSA; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; RECTAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, RECTAL; ANIMALS; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; EPITOPES; FEMALE; HAPTENS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; TRINITROBENZENES; TRINITROBENZENESULFONIC ACID;

EID: 0030239820     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Farmer, R. G. 1988.Clinical features, laboratory findings and course of Crohn's disease. In Inflammatory Bowel Disease, 3rd Ed. J. B. Kirsner and R. G. Shorter, eds. Lea & Febiger, Philadelphia, pp. 175-184.
2. Strober, W. 1985. Animal models of inflammatory bowel disease: an overview. Dig. Dis. Sci. 30:3S.
3. Sartor, R. B., W. J. Cromartie, D. W. Powell, and J. H. Schwab. 1985. Granulomatous enterocolitis induced by purified bacterial cell wall fragments. Gastroenterology 89:587.
4. Beck, P. L., G. P. Morris, A. W. Wade, M. Szewczuk, and J. L. Wallace. 1988. Immunological manipulation of disease progression in a rat model of chronic inflammatory disease of the colon. In Inflammatory Bowel Disease: Current Status and Future Approaches, R. P. MacDermott, ed. Elsevier, New York, p. 201.
5. Morris, G. P., P. L. Beck, M. S. Herridge, W. T. Depew, M. R. Szewczuk, and J. L. Wallace. 1989. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795.
6. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stüber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
7. Turk, J. L. 1975. Delayed Hypersensitivity, North Holland Publishing Company, Amsterdam, pp. 1-319.
8. Miller, S. D., and L. D. Butler. 1983. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses. J. Immunol. 131:77.
9. Greene, M. I., C. H. Ginsburg, and B. Benacerraf. 1982. The regulation of hapten-specific granuloma formation. Clin. Immunol. Immunopathol. 23:275.
10. Sundberg, J. P., C. O. Elson, H. Bedegian, and E. H. Birkenmeier. 1994. Inflammatory bowel disease involving the cecum in C3H/HeJ mice. Gastroenterology 107:1726.
11. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:274.
12. Sadlack, B., H. Merz, H. Schorle, A. Schimpil, A. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with disrupted interleukin-2 gene. Cell 75:253.
13. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
14. Strober, W., and R. O. Ehrhardt. 1993. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75:203.
15. Zhang, Z. Y., C. S. Lee, O. Lider, and H. Weiner. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145:2489.
16. Gesualdo, L., M. E. Lamm, and S. Emancipator. 1990. Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J. Immunol. 145:3684.
17. Khoury, S. J., O. Lider, A. Al-Sabbagh, and H. Weiner. 1990. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell. Immunol. 131:302.
18. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, and D. M. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 147:2155.
19. + T cells that secrete IFN-γ and IL-5. J. Immunol. 145:68.
20. + T cells provide B cell help. J. Exp. Med. 175:695.
21. Jackson, R. J., K. Fujihashi, J. Xu-Amano, H. Kiyono, C. O. Elson, and J. R. McGhee. 1993. Optimizing oral vaccines: induction of systemic and mucosal B cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61:4272.
22. Mega, J., J. R. McGhee, and H. Kiyono. 1992. Cytokine and Ig-producing cells in mucosal effector tissues: analyis of IL-5 and IFN-γ producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues. J. Immunol. 148:2030.
23. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa-associated tissues. J. Exp. Med. 178:1309.
24. Hurme, M., K. Varkila, and M. Sihvola. 1986. Induction of TNF-specific cytotoxic T lymphocyte memory in vivo in the absence of T helper cell activity. J. Immunol. 137:782.
25. VanCott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, M. Coste, P. B. Carter, H. Kiyono, and J. R. McGhee. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156:1504.
26. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun. 64:1516 .
27. Dieleman, L. A., C. O. Elson, G. S. Tennyson, and K. W. Beagley. 1996. Kinetics of cytokine expression during healing of acute colitis in mice. Amer. J. Physiology. In press.
28. Carter, P. B., and F. M. Collins. 1974. The route of enteric infection in normal mice. J. Exp. Med. 139:1189.
29. Riddell, R. H. 1988. Pathology and idiopathic inflammatory bowel disease. In Inflammation Bowel Disease, 3rd Ed. J. B Kirsner and R. G. Shorter, eds. Lea & Febiger, Philadelphia, pp. 97-164.
30. Zhang, Z. Y., C. S. Lee, O. Lider, and H. L. Weiner. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145:2489.
31. Bourdette, D. N., M. J. Turner, A. A. Vandenbark, and H. Offner. 1990. Characterization of basic protein-specific T cell lines selected from Lewis rats with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 26:81.
32. Sartor, R. B., W. J. Cromartie, D. W. Powell, and J. H. Schwab. 1985. Granulomatous enterocolitis induced by purified bacterial cell wall fragments. Gastroenterology 89:587.
33. Yang, H., and J. I. Rotter. 1992. The genetics of inflammatory bowel disease. In Inflammatory Bowel Disease. R. P. MacDermott and W. F. Stenson, eds. Elsevier, New York, pp. 17-51.
34. Roth, M.-P., G. M. Peterson, C. McElree, C. M. Vadheim, J. F. Panish, and J. I. Rotter. 1989. Familial recurrence risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 96:1016.
35. Copeland, N. G., N. A. Jenkins, D. J. Gilberg, J. T. Eppig, L. J. Maltais, J. C. Miller, W. F. Dietrich, A. Weaver, S. E. Lincoln, and R. G. Steen. 1993. A genetic linkage map of the mouse: current applications and future prospects. Science 262:57.
36. Baklien, K., and P. Brandtzaeg. 1975. Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon. Clin. Exp. Immunol. 22:197.
37. MacDermott, R. P., G. S. Nash, M. J. Bertovich, R. F. Mohrman, I. J. Kodner, D. L. Delacroix, and J. P. Vaerman. 1986. Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease. Gastroenterology 91:379.
38. Brandtzaeg, P., K. Valnes, H. Scott, T. O. Rognum, K. Bjerke, and K. Baklien. 1985. The human gastrointestinal secretory system in health and disease. Scand. J. Gastroenterol. 20:17.
39. Asherson, G. L., M. Zembala, M. A. C. C. Perera, B. Mayhew, and W. R. Thomas. 1977. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol. 33:145.
40. Kaulersch, W., C. Fiocchi, and T. A. Waldmann. 1988. Polyclonal nature of the intestinal lymphocyte populations in inflammatory bowel disease: a molecular genetic evaluation of the immunoglobulin and T cell antigen receptors. Gastroenterology 95:364.
41. Fiocchi, C. 1989. Lymphokines and the intestinal immune response. Role in inflammatory bowel disease. Immunol. Invest. 18:91.
42. Isaacs, K. L., R. B. Sartor, and S. Haskill. 1992. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplication. Gastroenterology 103:1587.
43. Cominelli, F., C. C. Nast, B. D. Clark, R. Schindler, R. Lierena, V. E. Eysselein, R. C. Thompson, and C. A. Dinarello. 1990. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J. Clin. Invest. 86:972.
44. + T cells in inflammatory bowel disease. Gastroenterology 101:1594.
45. Kobayashi, K., H. Asakura, Y. Hamada, T. Hibi, M. Watanabe, T. Yoshida, N. Watanabe, S. Miura, S. Aiso, and M. Tsuchiya. 1988. T lymphocyte subpopulations and immunoglobulin-containing cells in the colonic mucosa of ulcerative colitis; a morphometric and immunohistochemical study. J. Clin. Lab. Immunol. 25:63.
46. Fukushima, K., T. Masuda, H. Ohtani, I. Sasaki, Y. Funayama, S. Matsuno, and H. Nagura. 1990. Immunohistochemical characterization, distribution, and ultrastructure of lymphocytes bearing T cell receptor γδ in inflammatory bowel disease. Gastroenterology 101:670.
47. MacDermott, R. P., G. S. Nash, M. J. Bertovich, M. V. Seiden, M. J. Bragdon, and M. G. Beale. 1981. Alterations of IgM, IgG, and IgA synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease. Gastroenterology 81:844.
48. Scott, M. G. M. H. Nahm, K. Macke, G. S. Nash, M. J. Bertovich, and R. P. MacDermott. 1987. Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls. Clin. Exp. Immunol. 66:209.
49. Hibi, T., M. Ohara, K. Toda, A. Hara, H. Ogata, Y. Iwao, Y. Watanabe, Y. Hamada, K. Koboyashi, S. Aiso, and M. Tsuchiya. 1990. In vitro anti-colon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis. Gut 31:1371.
50. Mayer, L., D. Eisenhatdt, P. Salomon, W. Bauer, R. Plous, and L. Piccinini. 1991. Expression of class II molecules on intestinal epithelial cells in humans. Gastroenterology 100:3.
51. Strober, W., and S. P. James. 1986. The immunological basis of inflammatory bowel disease. J. Clin. Immunol. 6:415.
52. Keren, D. F., H. D. Appelman, W. O. Dobbins, J. J. Wells, B. Whisenant, J. Foley, R. Dieterle, and K. Geisinger. 1984. Correlation of histopathologic evidence of disease activity with the presence of immunoglobulin-containing cells in the colon of patients with inflammatory bowel disease. Hum. Pathol. 15:757.
53. Rosenkrans, P. C., C. J. Meijer, A. M. Van der Wal, C. J. Cornelisse, and J. Lindeman. 1980. Immunoglobulin-containing cells in inflammatory bowel disease of the colon: A morphometric and immunohistochemical study. Gut 21:941.
54. Scott, B. B., A. Goodall, P. Stephenson, and D. Jenkins. 1983. Rectal mucosa plasma cells in inflammatory bowel disease. Gut 24:519.
55. Kelt, K., T. O. Rognum, and P. Brandtzaeg. 1987. mucosal subclass distribution of IgG-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 93:919.
56. Asherson, G. L., M. Zembala, M. A. C. C. Perera, B. Mayhew, and W. R. Thomas. 1977. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell. Immunol. 33:145.
57. Mosmann, T. R., and R. L. Coffman. 1986. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
58. Street, N. E., and T. R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:171.
59. Marcinkiewicz, J., and B. M. Chain. 1990. Further studies on the regulation of lymphokine biosynthesis in contact sensitivity. Cytokine 2:344.
60. Brynskov, J., L. Freund, S. N. Rasmussen, K. Lauritsen, O. S. de Muckadell, N. Williams, A. S. MacDonald, R. Tanton, F. Molina, and M. C. Campanini. 1989. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N. Engl. J. Med. 321:845.
61. Mullin, G. E., A. J. Lazenby, M. L. Harris, T. M. Bayless, and S. P. James. 1992. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 102:1620.
62. Gurbindo, C., P. Russo, S. Sabbah, M. J. Lohoues, and E. Seidman. 1993. Interleukin-2 activity of colonic lamina propria mononuclear cells in a rat model of experimental colitis. Gastroenterology 104:964.
63. Asherson, G. L., and R. M. R. Barnes. 1975. Contact sensitivity in the mouse. II. Use of DNA synthesis in vivo to detemine location of immunologic unresponsiveness to picryl chloride. Immunology 24:495.
64. Marcinkiewicz, J. 1983. Suppression of contact sensitivity to picryl chloride. Interaction between T suppressor auxiliary cells, suppressor factors and macrophages. Arch. Immunol. Ther. Exp. 31:849.
65. Gautam, S. C., and J. R. Battisto. 1985. Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity. J. Immunol. 135:2975.
66. Richman, L. K., A. S. Graeff, R. Yarchoan, and W. Strober. 1981. Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding. J. Immunol. 126:2079.